Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.
For diabetes mellitus. Sold as Humulin R, Myxredlin. Every FDA application for this active ingredient.
As of Nov 14, 2026, FDA lists 2 applications for Insulin Human (sold as Humulin R, Myxredlin), first approved Oct 28, 1982, with 2 new uses approved and 0 published complete response letters.
First approved: Oct 28, 1982
Applications: 2
New uses approved: 2
Complete response letters: 0
First approved in the EU: Feb 21, 1997
First approved in Japan: Mar 23, 2011
What Pharmacies Pay
Median price per unit across package codes in CMS's weekly NADAC survey, Nov 11, 2026, before rebates; see every drug's price change
HUMULIN R 500 UNIT/ML KWIKPEN: $91.61 per MLBrand · 0% in a year
Approvals in the EU (EMA)
First approved in the EU 172 months after the US. Centrally authorised medicines, matched by ingredient; see all EU approvals
VelosulinNovo Nordisk A/S · Oct 7, 2002 · withdrawn
Approvals in Japan (PMDA)
First approved in Japan 341 months after the US. PMDA's English list since 2008, matched by ingredient; see all Japanese approvals
Novolin R FlexPen Novolin R, new ingredientDrugs with a new active ingredient indicated for the treatment of diabetes mellitus in cases where insulin therapy is indicated. · Novo Nordisk Pharma Ltd. · Mar 23, 2011
Clinical Trials
963 open or ongoing studies name this ingredient as an intervention, including as a comparator; newest first. See all
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient.Drugs@FDA
Lilly
Baxter Hlthcare Corp